Debates & Insight Sponsored Available on demand: What will changes to England's pharmacy... New measures proposed by the Government will impact community pharmacies across the UK.
Articles Healthcare systems aren’t making the most of biosimilars: ph... Biosimilars could save European and US healthcare systems billions - but more needs to be done to maximise their benefits, writes Richard Staines.
Articles Manchester's devolution revolution: will pharma get a seat a... Manchester will lead the way towards integrated care
News Japan follows UK in GSK's comeback tour for Blenrep The revitalisation of GSK's blood cancer therapy Blenrep continues with a second approval, in Japan, as a second-line treatment for multiple myeloma.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.